Score computed from 132 publicly published third-party lab results. Every input links to its source below.
If you buy through our link or code we may earn a commission. This never affects scores or rank position.
Yiwu Aozuo Trading Co is an unverified PeptideCensus listing. Trading company operating across multiple storefront domains; tracked for lookup. Its 132 published third-party results still appear on our compound boards, marked Unverified.
The Finnrick directory counts 132 published third-party results for Yiwu Aozuo Trading Co, the latest dated 10 Sept 2026. It appears on 9 compound boards; its best scored placement is #1 on the TB-500 board, scoring 53 from 6 tests.
Whichever seller you use, match the certificate to the lab's own records before trusting a vial: search its code in the Freedom Diagnostics lookup or check a Janoshik report with its key (how to verify a Janoshik report). A certificate covers one tested batch, so compare its batch number and date with the vial you receive.
| Compound | Rank | Score | Tests | Price/mg | Last test |
|---|---|---|---|---|---|
| TB-500 | #1 | 53 | 6 | $1.40 | 3 Aug 2026 |
| Tirzepatide | #4 | 90 | 31 | $0.40 | 16 Sept 2026 |
| Cagrilintide | #6 | 62 | 7 | — | 21 Mar 2026 |
| PT-141 | #11 | 72 | 3 | — | 20 May 2026 |
| Sermorelin | #12 | 35 | 3 | $1.90 | 14 Sept 2026 |
| GHK-Cu | #14 | 90 | 16 | $0.10 | 9 Oct 2026 |
| hCG | #15 | — | — | — | — |
| Ipamorelin | #20 | 74 | 10 | $0.60 | 10 Sept 2026 |
| Semaglutide | #23 | 70 | 2 | — | 30 Dec 2025 |
Every leaderboard placement we track; each row links to the full board and its source record. Rows without scores are rating-level listings the published testing has not yet covered.
Get a heads-up when new tests publish for vendors we track.
Free, unsubscribe anytime. Address is used for the digest and nothing else; see the privacy policy.